4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Aptorum Group Ltd (APM) operates in the Biotechnology industry and is headquartered in Princeton, United States with about 1 employees. Its market capitalization is roughly $1 million. In the fiscal year ended 2025-12-31, APM reported $0M in revenue and ($1M) in net income.
Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $1M | — |
| Gross Profit | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($2M) | ($3M) | ($11M) | ($17M) | — |
| Net Income | ($1M) | ($4M) | ($3M) | ($10M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2025-12-31 | 2025-09-30 | 2024-12-31 |
|---|---|---|---|
| Total Revenue | $0M | $0M | $0M |
| Operating Income (EBIT) | ($1M) | ($1M) | $1M |
| Net Income | ($0M) | ($1M) | ($1M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $19M | $16M | $21M | $21M | — |
| Total Liabilities | $5M | $4M | $5M | $13M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive APM viewer.
About TickerBase · Data methodology & sources